Synthesis, X-ray characterization and biological evaluation of some new 2-(4-methy-2-oxo-2H-chromen-7yloxy) acetamide derivatives

[1]  McCartney Makie,et al.  Practical medical microbiology , 2013 .

[2]  R. Siva,et al.  Ultrasound-promoted synthesis, biological evaluation and molecular docking of novel 7-(2-chloroquinolin-4-yloxy)-4-methyl-2H-chromen-2-one derivatives , 2013, Medicinal Chemistry Research.

[3]  Kristin K. Brown,et al.  Type IIA topoisomerase inhibition by a new class of antibacterial agents , 2010, Nature.

[4]  Rangappa S. Keri,et al.  2-Azetidinone Derivatives: Design, Synthesis, in vitro Antimicrobial, Cytotoxic Activities and DNA Cleavage Study. , 2010 .

[5]  M. Castanheira,et al.  Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species , 2010, Journal of Clinical Microbiology.

[6]  M. Noolvi,et al.  Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives. , 2010, European journal of medicinal chemistry.

[7]  Rangappa S. Keri,et al.  2-Azetidinone derivatives: design, synthesis, in vitro anti-microbial, cytotoxic activities and DNA cleavage study. , 2009, European journal of medicinal chemistry.

[8]  T. Smyth,et al.  A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins. , 2009, International journal of antimicrobial agents.

[9]  Y. Pommier,et al.  The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives , 2009, Molecular Cancer Therapeutics.

[10]  C. S. Reddy,et al.  Synthesis and in vitro study of novel bis-[3-(2-arylmethylidenimino-1,3-thiazol-4-yl)-4-hydroxy-2H-chromen-2-one-6-yl]methane and bis-[3-(2-arylidenhydrazo-1,3-thiazol-4-yl)-4-hydroxy-2H-chromen-2-one-6-yl]methane as potential antimicrobial agents , 2009 .

[11]  S. M. Asdaq,et al.  Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins. , 2008, European journal of medicinal chemistry.

[12]  R. Raghunathan,et al.  An Expedient Microwave-Assisted, Solvent-Free, Solid-Supported Synthesis of Pyrrolo[2,3-d]pyrimidine-pyrano[5,6-c]coumarin/[6,5-c]chromone Derivatives by Intramolecular hetero Diels—Alder Reaction. , 2008 .

[13]  B. Teicher.  Next generation topoisomerase I inhibitors: Rationale and biomarker strategies. , 2008, Biochemical pharmacology.

[14]  R. Raghunathan,et al.  An expedient microwave-assisted, solvent-free, solid-supported synthesis of pyrrolo[2,3-d]pyrimidine-pyrano[5,6-c]coumarin/[6,5-c]chromone derivatives by intramolecular hetero Diels–Alder reaction , 2008 .

[15]  S. Carradori,et al.  A novel class of selective anti-Helicobacter pylori agents 2-oxo-2H-chromene-3-carboxamide derivatives. , 2007, Bioorganic & medicinal chemistry letters.

[16]  Ruth H Flatman,et al.  Structure-Activity Relationships of Aminocoumarin-Type Gyrase and Topoisomerase IV Inhibitors Obtained by Combinatorial Biosynthesis , 2006, Antimicrobial Agents and Chemotherapy.

[17]  Giancarlo Cravotto,et al.  Chemistry and biological activity of natural and synthetic prenyloxycoumarins. , 2006, Current medicinal chemistry.

[18]  M. Ghate,et al.  Synthesis and in vivo analgesic and anti-inflammatory activity of some bi heterocyclic coumarin derivatives. , 2005, European journal of medicinal chemistry.

[19]  I. Kostova.  Synthetic and natural coumarins as cytotoxic agents. , 2005, Current medicinal chemistry. Anti-cancer agents.

[20]  D. Hadjipavlou-Litina,et al.  Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. , 2004, Current pharmaceutical design.

[21]  R. O’Kennedy,et al.  Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. , 2004, Current pharmaceutical design.

[22]  Jinn-Moon Yang,et al.  GEMDOCK: A generic evolutionary method for molecular docking , 2004, Proteins.

[23]  A. Escargueil,et al.  Catalytic topoisomerase II inhibitors in cancer therapy. , 2003, Pharmacology & therapeutics.

[24]  T. Kopylova,et al.  A Spectroscopic Study on Ground- and Excited-State Proton Transfer Reactions of Coumarin Derivatives , 2003 .

[25]  J. Bergman,et al.  Oxidative cyclization of N-methyl- and N-benzoylpyridylthioureas. Preparation of new thiazolo[4,5-b] and [5,4-b]pyridine derivatives , 2003 .

[26]  M. Nowakowska,et al.  The Effect of Cyclodextrins on the Photochemical Stability of 7-Amino-4-methylcoumarin in Aqueous Solution , 2001 .

[27]  S. Dastidar,et al.  Antimicrobial Activity of New Coumarin Derivatives , 2001, Arzneimittelforschung.

[28]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[29]  D. Hadjipavlou-Litina,et al.  Synthesis and biological evaluation of several coumarin-4-carboxamidoxime and 3-(coumarin-4-yl)-1,2,4-oxadiazole derivatives , 1998 .

[30]  C. Rodriguez,et al.  An antibiotic assay by the agar well diffusion method , 1990 .

[31]  Gl Ridgway,et al.  Practical Medical Microbiology , 1989 .

[32]  H. Blank,et al.  Isolation and recognition of dermatophytes on a new medium (DTM). , 1969, Archives of dermatology.

[33]  A. Goth.  THE ANTIBACTERIAL PROPERTIES OF DICUMAROL. , 1945, Science.